title: Responsive neurostimulation for the treatment of medically intractable epilepsy.
abstract: With an annual incidence of 50/100,000 people, nearly 1% of the population suffers from epilepsy. Treatment with antiepileptic medication fails to achieve seizure remission in 20-30% of patients. One treatment option for refractory epilepsy patients who would not otherwise be surgical candidates is electrical stimulation of the brain, which is a rapidly evolving and reversible adjunctive therapy. Therapeutic stimulation can involve direct stimulation of the brain nuclei or indirect stimulation of peripheral nerves. There are three stimulation modalities that have class I evidence supporting their uses: vagus nerve stimulation (VNS), stimulation of the anterior nuclei of the thalamus (ANT), and, the most recently developed, responsive neurostimulation (RNS). While the other treatment modalities outlined deliver stimulation regardless of neuronal activity, the RNS administers stimulation only if triggered by seizure activity. The lower doses of stimulation provided by such responsive devices can not only reduce power consumption, but also prevent adverse reactions caused by continuous stimulation, which include the possibility of habituation to long-term stimulation. RNS, as an investigational treatment for medically refractory epilepsy, is currently under review by the FDA. Eventually systems may be developed to enable activation by neurochemical triggers or to wirelessly transmit any information gathered. We review the mechanisms, the current status, the target options, and the prospects of RNS for the treatment of medically intractable epilepsy.
authors.affiliation: Beijing Neurosurgical Institute, Capital Medical University, Beijing, China. liuchong19860810@hotmail.com
authors.forename: Chong
authors.initials: C
authors.lastname: Liu
authors.forename: Xiong-Wei
authors.initials: XW
authors.lastname: Wen
authors.forename: Yan
authors.initials: Y
authors.lastname: Ge
authors.forename: Ning
authors.initials: N
authors.lastname: Chen
authors.forename: Wen-Han
authors.initials: WH
authors.lastname: Hu
authors.forename: Tan
authors.initials: T
authors.lastname: Zhang
authors.forename: Jian-Guo
authors.initials: JG
authors.lastname: Zhang
authors.forename: Fan-Gang
authors.initials: FG
authors.lastname: Meng
mesh_terms: D000818:Animals; D001921:Brain / Q000503:physiopathology*; D004599:Electric Stimulation Therapy; D004827:Epilepsy / Q000628:therapy*; D006801:Humans
keywords: AD; ANT; CMT; CN; Current status; DBS; Development; ECoG; EEG; HFES; MRF; Medically intractable epilepsy; PTZ; RBF; RNS; Responsive neurostimulation; SANTE; SLE; STN; SUDEP; Targets; VNS; afterdischarge; anterior nuclei of the thalamus; caudate nucleus; centromedian nucleus of the thalamus; deep brain stimulation; electrocorticogram; electroencephalogram; high-frequency electrical stimulation; mesencephalic reticular formation; pentylenetetrazol; rPMC; radial basis function; responsive neurostimulation; right primary motor cortex; seizure-like event; stimulation of the anterior nucleus of thalamus for epilepsy; subthalamic nucleus; sudden unexpected death in epilepsy; vagus nerve stimulation